Company information
Name, CVR number, address, industry and legal form are based on the Danish Central Business Register (CVR).
CVR / VirkThe information about ORIFARM GENERICS HOLDING A/S combines official Danish company and financial-statement data with indicators calculated by Valuatum Oy.
Name, CVR number, address, industry and legal form are based on the Danish Central Business Register (CVR).
CVR / VirkFinancial figures come from annual reports published through the Danish Business Authority. The latest financial year used is 2025.
Open the 2025 annual reportValuatum Oy calculates financial ratios, comparisons and credit-risk indicators from the available accounts. The results support analysis and do not constitute a standalone credit decision.
Valuatum OyORIFARM GENERICS HOLDING A/S (CVR number: 2734722-3) is a company from ODENSE. The company reported a net sales of 459.5 mEUR in 2025, demonstrating a growth of 88.1 % compared to the previous year. The operating profit percentage was at 60.6 % (EBIT: 278.3 mEUR), while net earnings were 273.1 mEUR. The profitability of the company measured by Return on Assets (ROA) was 10.8 %, which can be considered good and Return on Equity (ROE) was 12.1 %, which can be considered good. The equity ratio, a key indicator for solidity, stood at 70.6 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. ORIFARM GENERICS HOLDING A/S's liquidity measured by quick ratio was 0.3 which is at a very low level. Thus, the company is in an unstable financial position, with its liquid assets significantly undermatching its current liabilities. This severe liquidity deficiency may lead to financial distress and threaten the company's operational continuity.
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Volume | |||||
| Net sales | 244 299.00 | 459 463.00 | |||
| Gross profit | 190 643.00 | 309 186.00 | 326 755.00 | 243 237.00 | 467 921.00 |
| EBIT | 110 845.00 | 205 962.00 | 183 136.00 | 90 601.00 | 278 330.00 |
| Net earnings | 213 053.00 | 130 350.00 | 91 843.00 | 89 363.00 | 273 125.00 |
| Shareholders equity total | 2 479 781.00 | 2 095 298.00 | 2 187 191.00 | 2 125 068.00 | 2 399 752.00 |
| Balance sheet total (assets) | 3 214 708.00 | 3 705 850.00 | 3 482 474.00 | 3 421 509.00 | 3 400 939.00 |
| Net debt | 263 533.00 | 1 062 823.00 | 859 323.00 | 812 039.00 | 763 705.00 |
| Profitability | |||||
| EBIT-% | 37.1 % | 60.6 % | |||
| ROA | 12.7 % | 5.6 % | 5.1 % | 4.7 % | 10.8 % |
| ROE | 14.7 % | 5.7 % | 4.3 % | 4.1 % | 12.1 % |
| ROI | 14.1 % | 6.3 % | 5.7 % | 5.3 % | 11.6 % |
| Economic value added (EVA) | 56 561.48 | 20 044.49 | -18 609.14 | -83 918.96 | 66 774.74 |
| Solvency | |||||
| Equity ratio | 77.1 % | 56.5 % | 62.8 % | 62.1 % | 70.6 % |
| Gearing | 10.6 % | 50.7 % | 39.3 % | 38.2 % | 31.8 % |
| Relative net indebtedness % | 487.9 % | 185.5 % | |||
| Liquidity | |||||
| Quick ratio | 1.7 | 0.1 | 0.1 | 0.0 | 0.3 |
| Current ratio | 1.7 | 0.1 | 0.1 | 0.0 | 0.3 |
| Cash and cash equivalents | |||||
| Capital use efficiency | |||||
| Trade debtors turnover (days) | 0.1 | 6.8 | |||
| Net working capital % | - 464.3 % | - 135.0 % |
Check the creditworthiness of ORIFARM GENERICS HOLDING A/S before offering payment terms. The report combines financial figures, risk scores, credit rating, bankruptcy risk and a credit-limit recommendation in one PDF.
Automatic monthly billing is under development. The feature is not yet active in our system, but it is coming soon. You get access to the service immediately after registration, while billing is handled manually by email invoice for now.
By pressing the button below, you confirm that you have read the terms above and allow us to invoice you 20 EUR / month.
The AI Credit Risk Report contains the same core financial figures and risk measures as the Credit Risk Report. It also provides written analysis of the company's finances, risks, repayment capacity and assets, together with relevant context from web searches.
Company-specific, AI-assisted credit risk report in PDF format.
Reports can be tailored to your own credit process: content structure, peer groups, risk thresholds, delivery method and AI-analysis weightings can all be adapted to your needs.
Ask about a tailored solution: contact@creditreports.dk
The report is intended for an initial financial assessment. · The final credit decision and any further verification are always the user's responsibility. · One-time payment, no subscription.
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.